These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 97708)

  • 1. Behavioral supersensitivity to apomorphine following chronic narcotic treatment in the guinea pig.
    Carlson KR; Almasi J
    Psychopharmacology (Berl); 1978 May; 57(3):273-7. PubMed ID: 97708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time course of dopaminergic hypersensitivity following chronic narcotic treatment.
    Carlson KR; Almasi J
    Pharmacol Biochem Behav; 1979 Sep; 11(3):283-7. PubMed ID: 574284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of chronic levodopa on haloperidol induced behavioral supersensitivity in the guinea pig.
    Weiner WJ; Carvey P; Nausieda PA; Goetz CG; Klawans HL
    Life Sci; 1981 May; 28(19):2173-8. PubMed ID: 7195969
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of chronic levodopa on haloperidol-induced behavioral supersensitivity in the guinea pig.
    Weiner WJ; Carvey P; Nausieda PA; Goetz CG; Klawans HL
    Adv Neurol; 1982; 35():213-9. PubMed ID: 6890754
    [No Abstract]   [Full Text] [Related]  

  • 5. Behavioral supersensitivity to apomorphine and amphetamine after chronic high dose haloperidol treatment.
    Smith RC; Davis JM
    Psychopharmacol Commun; 1975; 1(3):285-93. PubMed ID: 1241453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of apomorphine on morphine analgesia during the state of dopaminergic supersensitivity after chronic treatment with haloperidol.
    Kamata K; Ogawa K; Noma S; Kameyama T
    J Pharmacobiodyn; 1986 Jan; 9(1):88-94. PubMed ID: 3712211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of narcotic analgesics with neuroleptics on behavioral measures of dopaminergic activity.
    Lal H; Gianutsos G; Puri SK
    Life Sci; 1975 Jul; 17(1):29-34. PubMed ID: 238089
    [No Abstract]   [Full Text] [Related]  

  • 8. Scopolamine modulates apomorphine-induced behavior in rats treated with haloperidol or SCH 23390.
    Butkerait P; Friedman E
    Eur J Pharmacol; 1988 Mar; 148(2):269-72. PubMed ID: 2897925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral evidence for dopaminergic supersensitivity following chronic treatment with methadone or chlorpromazine in the guinea pig.
    Eibergen RD; Carlson KR
    Psychopharmacology (Berl); 1976 Jul; 48(2):139-46. PubMed ID: 826925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential enhancement of behavioral sensitivity to apomorphine following chronic treatment of rats with (-)-sulpiride and haloperidol.
    Montanaro N; Dall'Olio R; Gandolfi O; Vaccheri A
    Eur J Pharmacol; 1982 Jun; 81(1):1-9. PubMed ID: 6889533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of melatonin on behavioral dopaminergic supersensitivity.
    Abílio VC; Vera JA; Ferreira LS; Duarte CR; Martins CR; Torres-Leite D; Ribeiro Rde A; Frussa-Filho R
    Life Sci; 2003 May; 72(26):3003-15. PubMed ID: 12706487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral evidence for dopaminergic supersensitivity after chronic haloperidol.
    Gianutsos G; Drawbaugh RB; Hynes MD; Lal H
    Life Sci; 1974 Mar; 14(5):887-98. PubMed ID: 4828404
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of buspirone on dopaminergic supersensitivity.
    Queiroz CM; Frussa-Filho R
    Life Sci; 1997; 61(4):371-82. PubMed ID: 9244363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of dopaminergic supersensitivity by a single dose of amphetamine.
    Haracz JL; Tseng LF
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Aug; 313(2):131-3. PubMed ID: 6106902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotypy and striatal dopamine receptor changes with 1-alpha-acetylmethadol (LAAM).
    Langley AE; Kirlangitis J; Lehman T
    Pharmacol Biochem Behav; 1981 May; 14(5):753-6. PubMed ID: 7195581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition by MK-801 of morphine-induced conditioned place preference and postsynaptic dopamine receptor supersensitivity in mice.
    Kim HS; Jang CG; Park WK
    Pharmacol Biochem Behav; 1996 Sep; 55(1):11-7. PubMed ID: 8870032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of chronic lithium on behavioral and biochemical indices of dopamine receptor supersensitivity in the rat.
    Pittman KJ; Jakubovic A; Fibiger HC
    Psychopharmacology (Berl); 1984; 82(4):371-7. PubMed ID: 6427831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of naloxone and morphine on dopamine agonist-induced stereotypy in rats and guinea pigs.
    Feigenbaum J; Yanai J; Moon B; Klawans H
    Neuropharmacology; 1983 Dec; 22(12A):1369-76. PubMed ID: 6686653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of opiates with dopamine receptors: receptor binding and behavioral assays.
    Carlson KR; Seeger TF
    Pharmacol Biochem Behav; 1982 Jan; 16(1):119-24. PubMed ID: 6173883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of apomorphine-, physostigmine- and pilocarpine-induced yawning after long-term treatment with neuroleptic or cholinergic agents.
    Ushijima I; Noda Y; Mizuki Y; Yamada M
    Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):180-8. PubMed ID: 6150689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.